Clinical Trial Update: Study of D07001-Softgel Capsules in Subjects With Gastrointestinal Cancer in Dose-Escalation Phase and in Subjects With Biliary Tract Cancer in Dose-Expansion Phase [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 dose-escalation and Phase 2 dose-expansion study of D07001-Softgel Capsules in gastrointestinal and biliary tract cancers completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Tract Cancer
• Gastrointestinal Cancer

Drugs mentioned

• D07001 Softgel-Capsules

Snippet

Sponsor: InnoPharmax Inc. | Conditions: Gastrointestinal Cancer, Biliary Tract Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-11-24